Cargando…

Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination

Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles. The underlying pathogenesis of PMR involves myeloid lineage activation with a high expression of pattern recognition receptors. In addition, vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Izuka, Shinji, Komai, Toshihiko, Natsumoto, Bunki, Shoda, Hirofumi, Fujio, Keishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987264/
https://www.ncbi.nlm.nih.gov/pubmed/34980802
http://dx.doi.org/10.2169/internalmedicine.8829-21
_version_ 1784682702917599232
author Izuka, Shinji
Komai, Toshihiko
Natsumoto, Bunki
Shoda, Hirofumi
Fujio, Keishi
author_facet Izuka, Shinji
Komai, Toshihiko
Natsumoto, Bunki
Shoda, Hirofumi
Fujio, Keishi
author_sort Izuka, Shinji
collection PubMed
description Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles. The underlying pathogenesis of PMR involves myeloid lineage activation with a high expression of pattern recognition receptors. In addition, vaccination against severe acute respiratory syndrome coronavirus 2 with mRNA-1273 functions as both an immunogen and intrinsic adjuvant. It leads to the activation of innate immunity, resulting in antibody production. We herein report the first case of PMR-like syndrome seven days after mRNA-1273 vaccination. Reassuringly, the symptoms, such as pain of the neck, shoulder girdle and pelvic girdle, as well as elevated inflammatory markers were resolved within a month without glucocorticoid or immunosuppressant administration.
format Online
Article
Text
id pubmed-8987264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-89872642022-04-26 Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination Izuka, Shinji Komai, Toshihiko Natsumoto, Bunki Shoda, Hirofumi Fujio, Keishi Intern Med Case Report Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles. The underlying pathogenesis of PMR involves myeloid lineage activation with a high expression of pattern recognition receptors. In addition, vaccination against severe acute respiratory syndrome coronavirus 2 with mRNA-1273 functions as both an immunogen and intrinsic adjuvant. It leads to the activation of innate immunity, resulting in antibody production. We herein report the first case of PMR-like syndrome seven days after mRNA-1273 vaccination. Reassuringly, the symptoms, such as pain of the neck, shoulder girdle and pelvic girdle, as well as elevated inflammatory markers were resolved within a month without glucocorticoid or immunosuppressant administration. The Japanese Society of Internal Medicine 2021-12-28 2022-03-15 /pmc/articles/PMC8987264/ /pubmed/34980802 http://dx.doi.org/10.2169/internalmedicine.8829-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Izuka, Shinji
Komai, Toshihiko
Natsumoto, Bunki
Shoda, Hirofumi
Fujio, Keishi
Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title_full Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title_fullStr Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title_full_unstemmed Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title_short Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
title_sort self-limited polymyalgia rheumatica-like syndrome following mrna-1273 sars-cov-2 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987264/
https://www.ncbi.nlm.nih.gov/pubmed/34980802
http://dx.doi.org/10.2169/internalmedicine.8829-21
work_keys_str_mv AT izukashinji selflimitedpolymyalgiarheumaticalikesyndromefollowingmrna1273sarscov2vaccination
AT komaitoshihiko selflimitedpolymyalgiarheumaticalikesyndromefollowingmrna1273sarscov2vaccination
AT natsumotobunki selflimitedpolymyalgiarheumaticalikesyndromefollowingmrna1273sarscov2vaccination
AT shodahirofumi selflimitedpolymyalgiarheumaticalikesyndromefollowingmrna1273sarscov2vaccination
AT fujiokeishi selflimitedpolymyalgiarheumaticalikesyndromefollowingmrna1273sarscov2vaccination